Skip to main content
CDC Website

Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to support hypothesis-generating research in transgender people with the objective of characterizing the biological and immunological impact of the interventions (hormones, drugs and surgical) used for gender reassignment and their impact on susceptibility to HIV and other sexually transmitted infections (STI).

Funding ID:
PAR-20-054
Application Due Date:
Application Contact
Ann
Devine
Grants Management Specialist
240.669.2988
adevine@niaid.nih.gov
Technical Contact
James
Cummins
Scientific/Research Contact NIAID
cumminsje@niaid.nih.gov
Funding Organization:
US Department of Health and Human Services National Institutes of Health
  • HIV/AIDS
  • International
  • National
  • HIV
  • STD/STI Prevention
Was this page helpful? Give Feedback